The Emerging Role of Artificial Intelligence in Cardiovascular Care: From Imaging to Predictive Analytics Authors: Taha Hatab, Maan Fares Published: 2026 ABSTRACT ABSTRACTArtificial intelligence (AI) is rapidly transforming cardiovascular medicine, evolving from theoretical promise to practical tools that improve diagnostic accuracy, streamline workflow, and enhance patient outcomes. Machine learning (ML) and deep learning systems now support automated image interpretation, disease detection, physiologic signal analysis, and individualized risk prediction. Large language models further reduce documentation burden and enable more efficient clinical communication. This review summarizes current applications of AI across cardiovascular care, with an example on the role of AI in predictive analytics in liver transplant candidates, an area where early risk identification may significantly alter outcomes. The article also explores emerging innovations, including the potential role of quantum computing, that may define the next era of cardiovascular medicine. INTRODUCTION Artificial intelligence (AI) has rapidly become integrated into nearly every sector of modern society, reshaping how individuals work, communicate, and make decisions.[1] Advances in machine learning (ML), deep learning (DL), and natural language processing have driven widespread adoption across industries, with the goals of improving efficiency, reducing costs, and augmenting human productivity.[2] As these technologies mature, concerns have emerged regarding workforce disruption, particularly the potential displacement of entry-level roles and a growing reliance on digital human–machine interfaces for routine decision-making and service delivery.[3] Health care, however, represents a distinct and more nuanced domain for AI integration. Rather than replacing clinicians, AI has thus far functioned primarily as an augmentative tool, enhancing diagnostic accuracy, streamlining workflows, and reducing administrative burden.[456] In clinical settings, where decision-making is complex, context-dependent, and ethically grounded, AI systems are best positioned as decision-support tools that complement, rather than supplant physician expertise. When thoughtfully implemented, AI may also help address escalating healthcare costs by optimizing resource utilization and allowing clinicians to focus on high-value patient-centered tasks, particularly in systems where clinician time constitutes a substantial portion of overall expenditure.[7] Cardiovascular medicine stands at the forefront of this transformation. Cardiovascular disease remains the leading cause of mortality and disability worldwide, accounting for over 20 million deaths annually and imposing an enormous economic burden on healthcare systems globally.[89] Simultaneously, cardiology has become increasingly data intensive, with exponential growth in advanced imaging modalities, continuous physiologic monitoring, electronic health records (EHRs), and high-dimensional omics data. Interpreting these complex datasets when maintaining efficiency, accuracy, and individualized patient care presents a growing challenge for clinicians. AI offers powerful solutions to these challenges across the cardiovascular continuum, including automated image interpretation, risk prediction, disease phenotyping, workflow optimization, and personalized treatment selection.[101112] Applications in echocardiography, cardiac computed tomography (CT), cardiac magnetic resonance (CMR) imaging, electrocardiography, and heart failure management have already demonstrated performance comparable to or exceeding expert-level interpretation in specific tasks.[1314] Importantly, these advances have the potential not only to improve diagnostic precision and clinical outcomes but also to enhance equity by expanding access to high-quality cardiovascular care in resource-limited settings.[15] In this review, we examine the current and emerging applications of AI in cardiovascular medicine, highlighting its role in augmenting clinical decision-making, improving efficiency, and addressing the growing demands placed on cardiologists. We also discuss key limitations, ethical considerations, and implementation challenges that must be addressed to ensure safe, equitable, and clinically meaningful integration of AI into cardiovascular practice. BRIEF REVIEW OF ARTIFICIAL INTELLIGENCE’S CONTINUOUS LEARNING CYCLE AI seeks to replicate aspects of human intelligence by enabling machines to recognize patterns, make predictions, and improve performance through feedback rather than explicit rule-based programming.[3] Artificial neural networks, which form the backbone of many modern AI systems, are computational architectures inspired by the organization and signaling behavior of biological neural networks in the human brain.[16] These networks consist of multiple interconnected layers of artificial neurons that transform input data through weighted connections and nonlinear activation functions to generate outputs of increasing weight.[17] Learning occurs through exposure to large datasets, during which network parameters are iteratively adjusted to minimize prediction error relative to labeled ground truth or outcome-based feedback. The conceptual origins of AI date back to the mid-20th century, including early work by Turing and McCarthy, but practical progress was limited for decades by insufficient computational power, small datasets, and ineffective learning algorithms.[1819] A major inflection point occurred with the development and formalization of backpropagation, a gradient-based optimization method that enables multilayer neural networks to efficiently propagate error signals backward through successive layers.[20] This approach, championed and refined by Geoffrey Hinton et al., allowed deep neural networks to correct internal weights iteratively and learn hierarchical feature representations from raw data.[21] The widespread adoption of backpropagation, combined with advances in graphical processing units and large-scale datasets, catalyzed the modern resurgence of DL across multiple domains, including medical imaging, speech recognition, and clinical decision support.[1622] AI is commonly subdivided into several overlapping categories. ML refers to a broad class of algorithms that identify statistical patterns in data and improve task performance without being explicitly programmed for each decision rule.[2324] DL is a specialized subset of ML that employs multilayer neural networks capable of modeling highly complex nonlinear relationships, often achieving expert-level or superhuman performance in narrowly defined tasks such as image classification and signal interpretation.[1617] Large language models (LLMs) represent a subcategory of DL, using transformer-based architectures trained on massive text corpora to learn probabilistic representations of language and generate coherent, context-aware natural language outputs.[2526] These models have introduced new opportunities for clinical documentation, literature synthesis, and decision support in healthcare settings. Despite differences in architecture and application, most AI systems follow a common continuous learning cycle. Data ingestion involves collecting raw inputs from sources such as imaging platforms, wearable sensors, physiologic monitors, and EHRs.[15] Preprocessing transforms raw data into structured and analyzable formats through normalization, labeling, noise reduction, and feature engineering.[26] Model training optimizes internal parameters using objective functions and gradient-based learning algorithms such as backpropagation.[2027] Validation assesses performance on independent datasets to evaluate generalizability and detect overfitting prior to clinical deployment. Deployment integrates trained models into real-world workflows, where they generate predictions or decision support outputs under human oversight.[4] Finally, feedback integration enables models to learn from existing data and outcomes, allowing continuous refinement when maintaining performance monitoring and safety constraints [Figure 1]. Continuous learning cycle in artificial intelligence systems When applied to health care and cardiovascular medicine, in particular, this continuous learning paradigm must be carefully governed to ensure transparency, robustness, equity, and clinical relevance. Regulatory frameworks such as the Food and Drug Administration’s Good Machine Learning Practice guidelines emphasize the importance of lifecycle oversight, dataset representativeness, and postdeployment performance monitoring for AI-enabled medical systems.[24] LARGE LANGUAGE MODELS IN CLINICAL CARE LLMs have demonstrated increasing utility in clinical care by improving documentation quality, streamlining clinical communication, and reducing administrative burden, key contributors to physician burnout.[2829] Administrative and clerical tasks, particularly electronic medical record (EMR) documentation, consume a substantial proportion of clinician time and are strongly associated with burnout and reduced job satisfaction.[2930] By transforming unstructured clinical interactions into structured, clinically meaningful text, LLMs allow clinicians to reallocate time and cognitive effort toward direct patient care rather than clerical work. A prominent real-world application is ambient clinical documentation, in which patient–clinician conversations are passively captured and processed using speech recognition combined with LLM-based natural language understanding. These systems generate encounter notes, including history of present illness, review of systems, assessment, and plan, that are subsequently reviewed and finalized by clinicians within the EMR. Early evaluations of ambient documentation tools have demonstrated reductions in after-hour documentation (“pajama time”), improved note completeness, and high clinician satisfaction without compromising documentation accuracy or clinical nuance.[3031] Beyond documentation, LLMs are increasingly used to accelerate clinical communication, including drafting patient portal responses, discharge summaries, referral letters, and interdisciplinary handoffs. In these settings, LLMs assist by synthesizing relevant clinical data, applying appropriate medical terminology, and tailoring tone for clinician-facing or patient-facing communication, with clinician oversight ensuring safety and accuracy.[32] LLMs may also support clinical decision-making workflows by summarizing complex longitudinal records, extracting salient trends from laboratory and imaging data, and contextualizing guideline-based recommendations at the point of care. While not a substitute for clinical judgment, these tools function as cognitive extenders, particularly in information-dense and high-volume environments such as cardiovascular medicine.[3334] Collectively, these applications illustrate how LLMs are transitioning from experimental technologies to integrated components of clinical workflows. When thoughtfully implemented with appropriate governance, transparency, and clinician oversight, LLMs have the potential to improve efficiency, documentation quality, and clinician well-being across modern healthcare systems [Figure 2]. Core applications of large language models in clinical care ARTIFICIAL INTELLIGENCE IN CARDIOVASCULAR IMAGING AI has rapidly become integral to cardiovascular imaging by improving reproducibility, accelerating image interpretation, and enhancing quantitative accuracy across echocardiography, CT, positron emission tomography (PET), and CMR imaging.[41035] These advances are particularly valuable as imaging volumes increase and clinicians are tasked with integrating growing amounts of complex data into time-sensitive clinical decisions. In echocardiography, AI-driven algorithms have demonstrated the ability to automate image acquisition, view recognition, and chamber quantification, including left ventricular volumes and ejection fraction, with accuracy comparable to expert readers.[1036] Automated measurements reduce inter- and intraobserver variability and shorten analysis time, supporting more consistent assessments across operators and institutions.[3637] AI-based tools have also shown promise in strain analysis and valvular assessment, further expanding quantitative capabilities in routine practice.[37] In cardiac CT and PET, AI facilitates automated coronary calcium scoring, plaque detection and characterization, and myocardial perfusion analysis with improved consistency and efficiency.[3538] DL approaches enable rapid segmentation of coronary arteries, identification of high-risk plaque features, and reduction of image noise, potentially improving diagnostic accuracy when maintaining or reducing radiation exposure.[3839] In PET imaging, AI-assisted reconstruction and analysis improve image quality and streamline quantitative perfusion assessment.[39] CMR imaging has similarly benefited from AI applications, particularly in automated ventricular segmentation, tissue characterization, and accelerated image reconstruction.[4041] DL-based reconstruction techniques significantly shorten acquisition times when preserving image quality, enabling broader clinical adoption of advanced CMR protocols.[4142] Automated analysis of ventricular volumes, function, and late gadolinium enhancement reduces postprocessing time and improves reproducibility, facilitating more efficient interpretation of complex datasets. When integrated thoughtfully into clinical practice, these tools augment-not replace-physician expertise and help meet the growing demands of modern cardiovascular care [Figure 3]. Applications of artificial intelligence in cardiovascular imaging ELECTROPHYSIOLOGY AND REMOTE MONITORING In electrophysiology, AI-enabled remote monitoring has the potential to extend high-quality arrhythmia care to underserved or geographically remote populations when reducing healthcare costs and improving clinical outcomes.[4344] The growing adoption of implantable cardiac devices, wearable sensors, and consumer-grade technologies has generated large volumes of continuous rhythm data, creating an ideal environment for AI-driven analytics to enhance signal interpretation and clinical efficiency.[45] AI algorithms applied to remote rhythm monitoring enable continuous surveillance, automated arrhythmia detection, and intelligent alert triaging, substantially reducing false-positive alerts and clinician workload.[11] In patients with implantable cardioverter-defibrillators, pacemakers, and insertable cardiac monitors, ML-based systems have demonstrated improved accuracy in detecting atrial fibrillation, ventricular arrhythmias, and device-related abnormalities compared with conventional rule-based approaches.[1146] Earlier detection of clinically actionable arrhythmias facilitates prompt intervention, which has been associated with reductions in stroke risk, inappropriate shocks, and unplanned hospitalizations.[4446] Remote monitoring has also been shown to improve outcomes and efficiency in randomized and real-world studies. Trials such as TRUST, IN-TIME, and CONNECT demonstrated that remote device monitoring reduces time to clinical decision-making, decreases in-person clinic visits, and may improve survival in selected heart failure and device populations.[444748] AI-enhanced triage systems build on these findings by prioritizing high-risk alerts and minimizing alert fatigue, a growing challenge in contemporary electrophysiology practice. Looking forward, AI-enabled remote monitoring may facilitate hub-and-spoke care models in which centralized tertiary or quaternary centers provide real-time rhythm interpretation, intensive care unit telemetry oversight, and clinical decision support for smaller or rural hospitals. When integrated with telemedicine and appropriate governance frameworks, this approach could extend subspecialty electrophysiology expertise virtually, improving access, efficiency, and safety when preserving local care delivery. PERIOPERATIVE CARDIAC RISK ASSESSMENT AI, including LLMs, is increasingly being incorporated into perioperative cardiac risk assessment to enhance risk stratification, clinical decision support, and workflow efficiency. By integrating large, multimodal datasets, such as clinical history, laboratory values, imaging findings, electrocardiography, and procedural variables, AI-based approaches can identify complex, nonlinear risk patterns that are often not captured by traditional scoring systems. In parallel, LLMs support perioperative care by synthesizing longitudinal medical records, summarizing prior cardiac evaluations, assisting with guideline-based recommendations, and facilitating multidisciplinary communication among cardiology, anesthesia, and surgical teams, thereby improving both the accuracy and efficiency of preoperative cardiovascular assessment. For example, liver transplant candidates represent a particularly challenging population due to advanced systemic disease, profound hemodynamic stress, and a high prevalence of occult cardiovascular pathology, making accurate perioperative cardiac risk prediction essential.[4950] Conventional risk models based on linear statistical methods may be limited in this setting, as they frequently fail to capture nonlinear relationships and high-order interactions among clinical variables.[43] In our experience, modern AI approaches offer meaningful advantages over traditional models by more effectively modeling these complex relationships.[51] In a cohort of 1459 liver transplant candidates, logistic regression demonstrated modest discriminatory performance with an area under the receiver operating characteristic curve (AUROC) of 0.66 (95% confidence interval [CI]: 0.57–0.74), whereas the XGBoost model achieved superior discrimination with an AUROC of 0.71 (95% CI: 0.63–0.79). These findings suggest that AI-based models may enable more precise and individualized perioperative cardiac risk stratification in the perioperative situation, with important implications for preoperative evaluation, resource allocation, and clinical decision-making in this high-risk population. PRECISION MEDICINE AI is poised to accelerate biomedical discovery by enabling advanced genetic analysis, molecular pattern recognition, and drug development. For instance, ML algorithms have been used to identify novel pathogenic variants in cardiomyopathy genes, uncover previously unrecognized molecular signatures in heart failure, and predict patient-specific responses to targeted therapies in oncology–cardiology intersections.[5253] These capabilities allow for more precise disease phenotyping and support the development of individualized therapeutic strategies tailored to each patient’s unique biological profile. AI-driven models increasingly integrate genomic, clinical, and imaging data to create personalized “digital twins” that simulate a patient’s physiology and disease trajectory. In cardiology, digital twin models have been applied to predict hemodynamic responses to structural interventions, forecast arrhythmia risk, and model pharmacologic responses in complex multimorbid patients, enabling clinicians to optimize treatment plans, guide therapeutic selection, and move precision medicine from a conceptual goal toward routine clinical application.[54] ETHICAL AND OPERATIONAL CONSIDERATIONS The adoption of AI in cardiovascular medicine demands careful attention to ethical and operational challenges. Bias in training datasets can exacerbate existing health inequities, while limited transparency and explainability may reduce clinician trust and accountability.[5556] Robust cybersecurity is critical, as AI systems and associated medical data are high-value targets for attacks. Equally important is maintaining clinician oversight to prevent overreliance, deskilling, and erosion of human judgment. When thoughtfully implemented, AI should function as an adjunct to enhance clinical reasoning and patient-centered care, rather than as a replacement for human decision-making.[3257] Healthcare institutions are increasingly recognizing the need for structured internal accountability mechanisms to oversee AI-enabled digital health technologies throughout their lifecycle.[58] Establishing centralized, multidisciplinary review bodies with expertise in clinical care, regulatory affairs, engineering, and ethics can help systematically assess risk, ensure alignment with evolving regulatory standards, and promote adherence to quality management practices. Such governance frameworks not only mitigate potential patient harm but also support scalable, responsible innovation by providing clear guidance for development, validation, and deployment within complex health system environments [Figure 4]. Ethical and operational considerations for artificial intelligence in cardiovascular medicine CONCLUSION AI is reshaping cardiovascular medicine, enhancing diagnostic accuracy, personalizing risk assessment, and enabling more proactive, data-driven management. Its promise is substantial, but important risks remain, including the potential for clinician deskilling and erosion of human oversight. The future of cardiology will depend on harnessing AI ethically and collaboratively, ensuring that these technologies strengthen not supplant clinical judgment. Conflicts of interest There are no conflicts of interest.